Thiazolidinediones, Cardiovascular Disease and Cardiovascular Mortality: Translating Research Into Action For Diabetes (TRIAD)

BACKGROUND: Studies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (CVD) and questioned whether the two available TZDs, rosiglitazone and pioglitazone, have different CVD risks. We compared CVD incidence, cardiovascular (CV) and all-cause mortality in type 2 diabetic p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bilik, Dori, McEwen, Laura N., Brown, Morton B., Selby, Joe V., Karter, Andrew J., Marrero, David G., Hsiao, Victoria C., Tseng, Chien-Wen, Mangione, Carol M., Lasser, Norman L., Crosson, Jesse C., Herman, William H.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3548906/
https://ncbi.nlm.nih.gov/pubmed/20583206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.1954
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki